✦ LIBER ✦

Imaging before and after multimodal treatment for malignant pleural mesothelioma

✍ Scribed by D. Fiore; V. Baggio; G. Sotti; P. C. Muzzio

Publisher: Springer
Year: 2006
Tongue: Italian
Weight: 779 KB
Volume: 111
Category: Article
ISSN: 0033-8362
DOI: 10.1007/s11547-006-0034-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Multimodality treatment programs for mal

Multimodality treatment programs for malignant pleural mesothelioma using high-dose hemithorax irradiation

✍ K. Mattson; L.R. Holsti; L. Tammilehto; P. Maasilta; S. Pyrhönen; M. Mäntylä; M. 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 994 KB

Survival and relapse pattern after trimo

Survival and relapse pattern after trimodality therapy for malignant pleural mesothelioma

✍ Kenichi Okubo; Makoto Sonobe; Takuji Fujinaga; Tsuyoshi Shoji; Hiroaki Sakai; Ry 📂 Article 📅 2009 🏛 Springer Japan 🌐 Japanese ⚖ 282 KB

Symptomatic and quality of life changes

Symptomatic and quality of life changes after extrapleural pneumonectomy for malignant pleural mesothelioma

✍ Vincenzo Ambrogi; Davide Mineo; Antonio Gatti; Eugenio Pompeo; Tommaso C. Mineo 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB

Malignant pleural mesothelioma after rad

Malignant pleural mesothelioma after radiation therapy for breast cancer. A report of two additional patients

✍ Vickie R. Shannon; Jonathan C. Nesbitt; Herman I. Libshitz 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 482 KB 👁 2 views

Computed tomography and magnetic resonan

Computed tomography and magnetic resonance imaging findings before and after treatment of patients with malignant external otitis

✍ Khaled Al-Noury; Alsaid Lotfy 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 682 KB

A phase II study of gemcitabine in patie

A phase II study of gemcitabine in patients with malignant pleural mesothelioma

✍ Jan P. van Meerbeeck; Paul Baas; Channa Debruyne; Harry J. Groen; Chris Manegold 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

## BACKGROUND. Gemcitabine has shown activity in patients with less chemosensitive solid tumors. Phase II screening of novel drugs is an accepted method with which to investigate new therapies in malignant mesothelioma. The European Organization for Research and Treatment of Cancer-Lung Cancer Coo